2021
DOI: 10.1021/acsami.1c09823
|View full text |Cite
|
Sign up to set email alerts
|

An Activatable Host–Guest Conjugate as a Nanocarrier for Effective Drug Release through Self-Inclusion

Abstract: There is a challenge in supramolecular chemotherapy for constructing a system equipped with both sufficient protection and high-efficiency release of drugs. To this end, a new strategy of an activatable host–guest conjugate with self-inclusion property is proposed. Based on the binding affinity gain of intramolecular host–guest self-inclusion, an activatable host–guest conjugate was designed, bearing cucurbit[7]­uril as the host, an alkyl ammonium moiety as the guest, and the redox-responsive disulfide linkage… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
28
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(28 citation statements)
references
References 51 publications
0
28
0
Order By: Relevance
“…Wu and co-workers used disulfide bonds to link two CB [7] spacer alkylammonium conjugates to form an activatable host−guest conjugate named DCBSS. 86 This system can encapsulate the drug oxaliplatin molecule through host−guest interaction, and due to the nature of the disulfide bond in the system that is reducible to thiol, it can trigger the self-inclusion of CB [7] and alkylammonium, resulting in the effective release of oxaliplatin. In another way, Yue and coworkers developed CB [7] covalently modified Fe 3 O 4 NPs, which later enabled CB [7] to bind to amantadine via host− guest interactions, ultimately enabling targeted drug delivery and specific drug release.…”
Section: Cucurbit[n]urils Nanodrug Carriers Based On Hostmentioning
confidence: 99%
See 1 more Smart Citation
“…Wu and co-workers used disulfide bonds to link two CB [7] spacer alkylammonium conjugates to form an activatable host−guest conjugate named DCBSS. 86 This system can encapsulate the drug oxaliplatin molecule through host−guest interaction, and due to the nature of the disulfide bond in the system that is reducible to thiol, it can trigger the self-inclusion of CB [7] and alkylammonium, resulting in the effective release of oxaliplatin. In another way, Yue and coworkers developed CB [7] covalently modified Fe 3 O 4 NPs, which later enabled CB [7] to bind to amantadine via host− guest interactions, ultimately enabling targeted drug delivery and specific drug release.…”
Section: Cucurbit[n]urils Nanodrug Carriers Based On Hostmentioning
confidence: 99%
“…The other enables drug release through a functional bond between two CB­[ n ]­s groups. Wu and co-workers used disulfide bonds to link two CB[7] spacer alkylammonium conjugates to form an activatable host–guest conjugate named DCBSS . This system can encapsulate the drug oxaliplatin molecule through host–guest interaction, and due to the nature of the disulfide bond in the system that is reducible to thiol, it can trigger the self-inclusion of CB[7] and alkylammonium, resulting in the effective release of oxaliplatin.…”
Section: Other Supramolecular Nanodrug Carriers Based On the Host–gue...mentioning
confidence: 99%
“…However, this covalent approach suffers from the long reaction time (e.g., 2 days) and the competitive reactions from the thiol and amine groups. To construct a fast and simple method for systemic delivery of peptide pharmaceuticals, Wang et al based on the concept of non-covalent supramolecular chemotherapy (Chen et al, 2017;Chen et al, 2018a;Wu et al, 2021), proposed a strategy of supramolecular peptide therapeutics . Owning to the strong host-guest interaction between the cucurbit[7]uril (CB[7]) and N-terminal phenylalanine (N-Phe) residue in the peptide (binding constant ∼2 × 10 6 M −1 ), the N-Phe-containing KLAK peptides were carried by the CB[7]-PEG copolymers in a simple (mixing in the aqueous solution) and fast (several minutes) manner with a high peptide encapsulation efficiency (>97%) under the peptide concentration of 0.5 mM.…”
Section: Applications In Cancer Therapymentioning
confidence: 99%
“…Supramolecular polymers refer to chain-like aggregates of monomers linked by non-covalent bonds, which are held together by highly directional secondary and reversible interactions and possess polymeric properties in solution and in bulk. 1,2 The non-covalent bonds can be multiple hydrogen bonds, [3][4][5][6][7][8] p-p interactions, [9][10][11][12][13][14] host-guest interactions [15][16][17][18][19][20] and metal coordination interactions. [21][22][23][24][25] Supramolecular polymers have self-healing, degradable, and regenerative properties, which are often used to design responsive, self-healing, and environmentally friendly materials.…”
Section: Introductionmentioning
confidence: 99%